An open-label observation study of topiramate administration as adjuvant therapy for focal epilepsy, Lennox-Gastaut syndrome epileptic seizures and generalized tonoclonic seizures in adults and children aged 2 years and older.

Trial Profile

An open-label observation study of topiramate administration as adjuvant therapy for focal epilepsy, Lennox-Gastaut syndrome epileptic seizures and generalized tonoclonic seizures in adults and children aged 2 years and older.

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Oct 2009

At a glance

  • Drugs Topiramate (Primary)
  • Indications Epilepsy; Lennox-Gastaut syndrome; Tonic-clonic epilepsy
  • Focus Adverse reactions
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 19 Oct 2007 Status changed from in progress to completed.
    • 05 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top